Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron vs Palonosetron with Aprepitant for PONV
NCT02597907Completed
- Sponsor
- Kyungpook National University Hospital
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of palonosetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Kyungpook National University Hospital. Primary endpoint: The Incidence of Postoperative Nausea and Vomiting at 24 hours. Started Jul 2014; status: completed.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02597907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597907.